Lemaitre Vascular (LMAT) Current Deferred Revenue (2018 - 2019)
Lemaitre Vascular (LMAT) reported Current Deferred Revenue of $188000.0 for Q2 2019, down 80.23% year-over-year from $951000.0 in Q2 2018, and down 48.91% quarter-over-quarter from $368000.0 in Q1 2019.
Lemaitre Vascular (LMAT) Current Deferred Revenue (2018 - 2019) Analysis & Trends
Lemaitre Vascular (LMAT) has 2 years of Current Deferred Revenue data on file, last reported at $188000.0 in Q2 2019.
- Current Deferred Revenue for Q2 2019 came in at $188000.0, down 80.23% year-over-year; the trailing twelve-month figure through Jun 2019 was $188000.0 (down 80.23% YoY), and the FY2018 annual result was $552000.0, changed N/A from the prior year.
- Current Deferred Revenue fell to $188000.0 in Q2 2019 per LMAT's latest filing, from $368000.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $951000.0 in Q2 2018 and troughed at $188000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Lemaitre Vascular | 2.12 Bn | 1.75 Bn | 48.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 188,000.00 |
| Mar 31, 2019 | 368,000.00 |
| Dec 31, 2018 | 552,000.00 |
| Sep 30, 2018 | 752,000.00 |
| Jun 30, 2018 | 951,000.00 |